Geoffrey Von Maltzahn
About Geoffrey Von Maltzahn
Geoffrey Von Maltzahn is a prominent entrepreneur and scientist, currently serving as the Founding CEO and Board Member of multiple biotechnology companies, including Quotient Therapeutics and Cobalt Biomedicine. He holds a PhD in Biomedical Engineering and Medical Physics from the Massachusetts Institute of Technology and has received numerous awards for his contributions to the field.
Work at Generate Biomedicines
Geoffrey Von Maltzahn serves as the Founding CEO and Board Member at Generate Biomedicines, Inc. since 2017. The company is based in Cambridge, Massachusetts, and focuses on developing innovative biomedicines using advanced computational techniques. Under his leadership, Generate Biomedicines aims to transform the drug discovery process and improve therapeutic outcomes.
Current Roles and Leadership Positions
In addition to his role at Generate Biomedicines, Geoffrey Von Maltzahn holds several leadership positions in various organizations. He is the Founding CEO of Quotient Therapeutics since 2022, Founding CEO and Board Member at Cobalt Biomedicine, Inc. since 2016, and Founding CEO and Chairman of the Board at Tessera Therapeutics since 2018. He also co-founded Sana Biotechnology, Inc. and serves as a Board Member, contributing to advancements in biotechnology.
Education and Expertise
Geoffrey Von Maltzahn has an extensive educational background in biomedical engineering and chemical engineering. He earned his PhD in Biomedical Engineering and Medical Physics from the Massachusetts Institute of Technology from 2005 to 2010. Prior to that, he completed his SB in Chemical Engineering at MIT from 1999 to 2003 and obtained his MS in Bioengineering from the University of California, San Diego from 2003 to 2005.
Professional Background
Geoffrey Von Maltzahn has a diverse professional background in biotechnology and pharmaceuticals. He co-founded Sienna Biopharmaceuticals and served as Co-Founder and CTO at Seres Therapeutics, where he led the discovery of SER-109. He has also held positions at Axcella Health and Flagship Pioneering, where he is a General Partner. His experience spans over 15 years in the industry, contributing to multiple successful ventures.
Awards and Recognition
Geoffrey Von Maltzahn has received numerous awards and honors throughout his career. He is recognized in Business Insider's 30 under 40 young leaders and Endpoints 20 under 40. He was awarded the prestigious Lemelson-MIT Student Prize for his contributions to invention and innovation. His work has been acknowledged by various media outlets, including the World Economic Forum, Forbes, and CNN.